Cameli, P.; Bargagli, E.; Bergantini, L.; d’Alessandro, M.; Giugno, B.; Gentili, F.; Sestini, P.
Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study. Antioxidants 2021, 10, 1350.
https://doi.org/10.3390/antiox10091350
AMA Style
Cameli P, Bargagli E, Bergantini L, d’Alessandro M, Giugno B, Gentili F, Sestini P.
Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study. Antioxidants. 2021; 10(9):1350.
https://doi.org/10.3390/antiox10091350
Chicago/Turabian Style
Cameli, Paolo, Elena Bargagli, Laura Bergantini, Miriana d’Alessandro, Bruna Giugno, Francesco Gentili, and Piersante Sestini.
2021. "Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study" Antioxidants 10, no. 9: 1350.
https://doi.org/10.3390/antiox10091350
APA Style
Cameli, P., Bargagli, E., Bergantini, L., d’Alessandro, M., Giugno, B., Gentili, F., & Sestini, P.
(2021). Alveolar Nitric Oxide as a Biomarker of COVID-19 Lung Sequelae: A Pivotal Study. Antioxidants, 10(9), 1350.
https://doi.org/10.3390/antiox10091350